Shona Davies and Sean Nicholson: How Do You Define “Engagement?”

In this 3-minute audio snippet, Shona L. Davies, Communications & Programme Leader, Univadis, and Sean Nicholson, Senior Director, Social Media, Intouch Solutions, define what they mean by social media

Tom Stossel: Debunking the “Conflict-of-Interest Narrative”

In this 5-minute audio snippet, Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, talks about what he calls the 'Conflict-of-Interest Narrative' or Myth, which is the subject of his new book, PharmaPhobia.

Jessica Federer: Empower Pharma Employees to Advance Digitalization in Your Organization

In this 1-minute audio snippet, Jessica Federer, Head of Digital Development at Bayer, talks about how Bayer employees its employees to advance the digitalization of the organization.

Peter Houston: Could Pharma Use Tumblr and Survive?

In this 3-minute audio snippet, Peter Houston, founder of Flipping Pages Media Ltd, discusses the pros and cons of Tumblr and whether it is possible for pharma marketers to get involved with Tumblr. Is it too Early?

Preeti Pinto: How Marketers & Regulatory People Can Just Get Along

In this 3-minute audio snippet, Preeti Pinto, a regulatory consultant and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca, talks about how regulatory-savvy pharma marketers are in a better position to challenge their regulatory colleagues when they say 'No.'

Pharmaguy™’s Twitter Stream – Q4 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Pharmaguy™’s Twitter Stream – Q2 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

The Annual Pharmaguy™ Pioneer Award

Rather than recognizing specific campaigns, the Pharmaguy™ Pioneer Award gives kudos to a pharmaceutical executive or team who has 'pioneered' in the use of social media or mobile for marketing, research, patient support, or corporate communications purposes.

The Misleading Marketing of “Low-T” Drugs

A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut.

Silja Chouquet: “DE-scribe” Medicines to Improve Adherence

In this 5-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, suggests that pharmaceutical companies apply resources and their brains to come up with a solution that helps people take their medication and use these insights to develop the next generation of treatments.
- Advertisement -